Sort
48,018 grants matching “immunotherapy”
CELL BIOLOGY AND MOLECULAR MECHANISMS OF HUMAN GAMMA/DELTA T CELL ACTIVATION
$383,280Kaushik Choudhuri · University Of Michigan At Ann Arbor · R01 · FY2019 · AI
CELL BIOLOGY AND MOLECULAR MECHANISMS OF HUMAN GAMMA/DELTA T CELL ACTIVATION
$383,280Kaushik Choudhuri · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
CD19-Specific T-Cell Therapy for Follicular Lymphoma
$383,257City Of Hope/Beckman Research Institute · R21 · FY2003 · CA
Detection and Activation of CD4+ T cells with Low Affinity TCRs
$383,226Marc K. Jenkins · University Of Minnesota · R01 · FY2023 · AI
Detection and Activation of CD4+ T cells with Low Affinity TCRs
$383,226Marc K. Jenkins · University Of Minnesota · R01 · FY2020 · AI
Detection and Activation of CD4+ T cells with Low Affinity TCRs
$383,226Marc K. Jenkins · University Of Minnesota · R01 · FY2022 · AI
Detection and Activation of CD4+ T cells with Low Affinity TCRs
$383,226Marc K. Jenkins · University Of Minnesota · R01 · FY2021 · AI
Detection and Activation of CD4+ T cells with Low Affinity TCRs
$383,226Marc K. Jenkins · University Of Minnesota · R01 · FY2019 · AI
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$383,223Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2024 · CA
Allergy Therapy with Chimeric Human Ig Proteins
$383,219Andrew Saxon · University Of California Los Angeles · R01 · FY2006 · AI
Gene Transfer and Somatic Cell Enginerring
$383,196Isabelle Riviere · Sloan-Kettering Inst Can Research · P30 · FY2023 · CA
Gene Transfer and Somatic Cell Enginerring
$383,196Isabelle Riviere · Sloan-Kettering Inst Can Research · P30 · FY2021 · CA
Gene Transfer and Somatic Cell Enginerring
$383,196Isabelle Riviere · Sloan-Kettering Inst Can Research · P30 · FY2020 · CA
Gene Transfer and Somatic Cell Enginerring
$383,196Isabelle Riviere · Sloan-Kettering Inst Can Research · P30 · FY2022 · CA
Monoclonal Antibodies for the Study of P. carinii
$383,164University Of Rochester · R01 · FY2005 · AI
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
$383,162Jun S Song · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$383,156Markus Mãschen · Yale University · R01 · FY2021 · CA
Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancer
$383,156Kurt A Schalper · Yale University · R01 · FY2025 · CA
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER
$383,156Qin Yan · Yale University · R01 · FY2021 · CA
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer
$383,156Abhijit Patel · Yale University · R01 · FY2018 · CA
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer
$383,156Abhijit Patel · Yale University · R01 · FY2020 · CA
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER
$383,156Qin Yan · Yale University · R01 · FY2020 · CA
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER
$383,156Qin Yan · Yale University · R01 · FY2019 · CA
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer
$383,156Abhijit Patel · Yale University · R01 · FY2017 · CA
Uncovering the heterogenous role of senescence in prostate immune suppression and tumorigenesis
$383,156Marcus A. Ruscetti · Univ Of Massachusetts Med Sch Worcester · R37 · FY2024 · CA